NCT05763849

Brief Summary

This project includes a parallel group randomized controlled trial comparing two psychological treatments: 1) Exposure-based Family Therapy (IE) vs. 2) Family Based Therapy (FBT) for low weight eating disorders with 12 month follow-up. Primary outcomes are expected body weight and clinical impairment. Three mechanisms of change (Autonomous Eating, Non-Judgmental Body Awareness, and Extinction Learning) will be examined in a process mediation models of change.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
19mo left

Started Mar 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress66%
Mar 2023Jan 2028

First Submitted

Initial submission to the registry

February 28, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 10, 2023

Completed
4 days until next milestone

Study Start

First participant enrolled

March 14, 2023

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2028

Last Updated

June 4, 2025

Status Verified

May 1, 2025

Enrollment Period

4.8 years

First QC Date

February 28, 2023

Last Update Submit

May 30, 2025

Conditions

Outcome Measures

Primary Outcomes (4)

  • Change in Expected Body Weight Percentage

    Expected body weight percentage will be calculated at baseline and end of treatment (6-months) to calculate difference.

    Baseline and 6-months

  • Change in Expected Body Weight Percentage

    Expected body weight percentage will be calculated at baseline and 1 year after treatment (18-months) to calculate difference.

    Baseline and 18-months

  • Change in Impairment

    Impairment is measured using the Clinical Impairment Assessment, which is a 16-item self-report measure of impairment from eating disorders. Responses are scored using 0, 1, 2, or 3 and the score is calculated using the sum of all items. Possible scores range between 0 - 48, with higher scores indicating more impairment and lower scores indicating less impairment. Change in impairment will be calculated using the baseline and end of treatment (6-months) scores from CIA.

    Baseline and 6-months

  • Change in Impairment

    Impairment is measured using the Clinical Impairment Assessment, which is a 16-item self-report measure of impairment from eating disorders. Responses are scored using 0, 1, 2, or 3 and the score is calculated using the sum of all items. Possible scores range between 0 - 48, with higher scores indicating more impairment and lower scores indicating less impairment. Change in impairment will be calculated using the baseline and 1 year after treatment (18-months) scores from CIA.

    Baseline and 18-months

Secondary Outcomes (8)

  • Change in Autonomous Eating

    Baseline and 6-months

  • Change in Autonomous Eating

    Baseline and 18-months

  • Change in Food Cue Learning

    Baseline and 6-months

  • Change in Food Cue Learning

    Baseline and 18-months

  • Change in Eating Disorder Symptoms

    Baseline and 6-months

  • +3 more secondary outcomes

Study Arms (2)

Interoceptive Exposure Treatment (IE)

EXPERIMENTAL

Interoceptive Exposure Therapy (IE) targets food avoidance, food exposure, and body image exposure.

Behavioral: Interoceptive Exposure Treatment (IE)

Family-Based Treatment (FBT)

ACTIVE COMPARATOR

Family-Based Therapy (FBT) focuses on parent-enforced contingencies, increasing value of eating, and decreasing the value of food avoidance.

Behavioral: Family-Based Treatment (FBT)

Interventions

Interoceptive Exposure Therapy (IE) targets food avoidance in Anorexia Nervosa. Each session the therapist weighs the patient, checks-in, and reviews weekly homework. Sessions occur weekly for 20 weeks, with the first session lasting 1.5 hours and the remaining sessions one hour. Early sessions include using exposure to foods and counterconditioning to pair a positive stimulus with a food that would typically produce food avoidance. Parents are trained to model this at home. Sessions mid-way through address the use of non-judgmental description of appearance during mirror exposure. Sessions at the end of the 20 weeks are focused on recognizing change, planning for future obstacles, and developing a relapse prevention plan to continue practicing distress tolerance, counter-conditioning, and food/body exposure.

Interoceptive Exposure Treatment (IE)

Family-Based Therapy (FBT) includes parent-enforced contingencies to increase value of eating and decrease the value of food avoidance. Each session the therapist weighs the patient, checks-in, and reviews weekly homework. Sessions occur weekly for 20 weeks, with the first session lasting 1.5 hours and the remaining sessions one hour. Sessions consist of checking in with the patient, discussion of the week's implementation of refeeding, and helping parents separate the illness from their child. In session 2, a family meal provides the therapist with an opportunity for direct observation of the familial interaction patterns around eating. The therapist makes careful and persistent requests for united parental action toward re-feeding and/or regulating eating habits, the primary concern at this point of the treatment, and the therapist tries to create and reinforce a strong parental alliance around efforts at feeding the child.

Family-Based Treatment (FBT)

Eligibility Criteria

Age12 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Aged 12-18
  • Speak English
  • Permission from pediatrician or equivalent to receive outpatient care
  • Clinically significant restriction of food intake by EDA-5 or evidence of persistent food avoidance from patient or guardians
  • Evidence of the inability to maintain greater than minimally low body weight based on BMI for age percentiles and growth trajectories

You may not qualify if:

  • Comorbid psychotic or bipolar disorder
  • Active suicidal ideation
  • Current substance dependence
  • Psychiatric medication initiated or dosage changes \<2 weeks from baseline
  • Major medical illness (e.g., diabetes mellitus, Crohn's disease, etc.)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Psychiatry, Eating and Weight Disorders Program

New York, New York, 10028, United States

RECRUITING

MeSH Terms

Conditions

Anorexia Nervosa

Condition Hierarchy (Ancestors)

Feeding and Eating DisordersMental Disorders

Study Officials

  • Thomas Hildebrandt, Psy.D.

    Icahn School of Medicine at Mount Sinai

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Thomas Hildebrandt, Psy.D.

CONTACT

Jessica Bibeau, MA

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This RCT includes a parallel group design including two psychological treatments (Exposure-based Family Therapy vs. Family Based Therapy) for low weight eating disorders with 12 month follow-up.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

February 28, 2023

First Posted

March 10, 2023

Study Start

March 14, 2023

Primary Completion (Estimated)

January 1, 2028

Study Completion (Estimated)

January 1, 2028

Last Updated

June 4, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will share

All of the individual participant data collected during the trial, after deidentification.

Shared Documents
STUDY PROTOCOL, ICF, ANALYTIC CODE
Time Frame
Specify Other Time FrameTwice yearly and for each publication
Access Criteria
Investigators whose proposed use of the data has been approved by an independent review committee identified for this purpose. Any purpose. Specify Other Mechanism Data will be made available through the National Institute of Mental Health Data Archive (NDA)

Locations